Stay updated on Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:09:32.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.2 and the prior funding-status notice was removed; these are site-wide maintenance updates that do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T03:15:26.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with links to cc.nih.gov and opm.gov for status updates. Updated the page revision stamp to v3.4.1, replacing the prior v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T01:51:43.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Glossary visibility has been added to the page. Metadata lines were updated to show 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' (replacing the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4').
    Difference
    0.2%
    Check dated 2026-01-28T00:27:44.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 on the page; no changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T19:16:06.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The Locations section now includes a New York site, replacing the previous 'New York Locations' label. The page revision shows v3.3.3 and the HHS Vulnerability Disclosure link has been removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:22:53.000Z thumbnail image

Stay in the know with updates to Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.